Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion type Assertion NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_head.
- NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion description "[However, MERTK is overexpressed or ectopically expressed in a wide variety of cancers, including leukemia, non-small cell lung cancer, glioblastoma, melanoma, prostate cancer, breast cancer, colon cancer, gastric cancer, pituitary adenomas, and rhabdomyosarcomas, potentially resulting in the activation of several canonical oncogenic signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_provenance.
- NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion evidence source_evidence_literature NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_provenance.
- NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion SIO_000772 23833304 NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_provenance.
- NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion wasDerivedFrom befree-2016 NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_provenance.
- NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_assertion wasGeneratedBy ECO_0000203 NP1092092.RAugt7PpsP22qO4RrMS9mkFpNrvT7ZSp7h2yjPMGk9TT4130_provenance.